![George Matcham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 275 844 $ al 30/09/2026
George Matcham is currently an Independent Director at Instil Bio, Inc. since 2018.
Formerly, Dr. Matcham was a Non-Executive Director at Chimeric Therapeutics Ltd. (Australia) from 2021 to 2023.
From 2017 to 2018, Dr. Matcham was SVP-CAR T CMC & Technology Development at Celgene Corp.
Dr. Matcham also served as Chief Operating Officer at Celgene Cellular Therapeutics.
Education includes graduate studies at the University of Cambridge and undergraduate and doctorate degrees from the University of Cardiff.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
INSTIL BIO, INC. 0,56 % | 11/06/2026 | 38.100 ( 0,56 % ) | 275 844 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| INSTIL BIO, INC. | Director/Miembro de la Junta | 01/09/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Director/Miembro de la Junta | 03/08/2023 |
| CELGENE | Corporate Officer/Principal | 01/06/2018 |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals | Director de Operaciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cardiff
 University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals | Health Technology |
Instil Bio, Inc.
 Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Chimeric Therapeutics Ltd. (Australia)
 Chimeric Therapeutics Ltd. (Australia) BiotechnologyHealth Technology Develops cell therapies for the tumors | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
